New approaches for cancer hazard assessment

03:1411 months ago

Chemical substances are subjected to assessment of genotoxic and carcinogenic effects before being marketed to protect man and the environment from health risks. For cancer hazard assessment, the long-term rodent carcinogenicity study is the current mainstay for the detection of nongenotoxic carcinogens. However, carcinogenicity studies are shown to have prominent weaknesses and are subject to ethical and scientific debate. A transition toward a mechanism-based weight of evidence approach is considered a requirement to enhance the prediction of carcinogenic potential for chemicals. At RIVM, we are working on this alternative approach for cancer hazard assessment, which makes optimal use of innovative (computational) tools and be less animal demanding.

For more information, click on the link in the video or read on here and here.
Contact the expert

Related

TPI.tv: improving science through animal-free innovations and research
TPI.tv videos
InnovationPolicyBeginner

TPI.tv: improving science through animal-free innovations and research

Introducing TPI.tv : a video platform by experts striving to improve science through animal-free innovations and research.
01:263 years ago
Five simple tricks for making your own video for TPI.tv
TPI.tv videos

Five simple tricks for making your own video for TPI.tv

This video shows you how to make a video yourself. It's really not that difficult! See also the submission page (https://tpi.tv/submit-a-video) for additional information.
01:234 years ago
Predictive computer models for protein binding
Innovation examples
HealthToxicologyIn silico

Predictive computer models for protein binding

In this video Linde Schoenmaker (Leiden University) explains how she and her colleagues are making computer models to predict the safety of new chemicals within the VHP4Safety project.
01:493 hours ago
Thyroid Hormone & Brain Development: animal-free models for human safety assessment
Innovation examples
HealthToxicologyIn vitro

Thyroid Hormone & Brain Development: animal-free models for human safety assessment

The environment can have a significant impact on a child's health even before birth. Brain development begins in the first trimester and continues until the age of 25, with thyroid hormone playing a critical role. During early pregnancy, the fetus depends on the mother's thyroid hormone, and a disruption in the thyroid hormone balance can lead to cognitive and motor impairments in the child. As part of the VHP4Safety project, we are developing in vitro tests to measure the developmental neurotoxic effects caused by disturbances thyroid hormone concentrations. Current testing guidelines do not always include testing for neurodevelopmental effects, highlighting the need for new non-animal methods. At the Erasmus Medical Center, human cell lines representing brain cell types are cultured to study the effect of chemicals on the thyroid hormone balance. RIVM uses human stem cells to create neuron-astrocyte networks that mimic brain development. By combining these different assays and models, we are creating a comprehensive human-based testing strategy to assess developmental neurotoxicity. These advances are a critical step toward eliminating animal testing while protecting the health and environment of future generations.
02:5316 days ago